For HR-positive/HER2-negative breast cancer, ADC therapies designed to deliver potent cytotoxic therapy directly to tumor cells are available and are preferred in the post-endocrine setting
Thiamine (Vitamin B1), Riboflavin (Vitamin B2), Niacinamide (Vitamin B3), d-Panthenol (pro-Vitamin B5), Pyridoxine (Vitamin B6), Folic Acid (Vitamin B9), Ascorbic Acid (Vitamin C), Vitamin A, Vitamin D, Levocarnitine, Dextrose
Gene expression analysis showed 127 genes altered in a direction that shifts from tissue destruction patterns toward active repair, with repair genes upregulated and inflammatory genes downregulated simultaneously
International Journal of Pharmacy and Pharmaceutical Sciences, 5(2), 34-36
This occurs when serum levels are high but the B12 isnt being properly taken up by tissues